#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Infection


Urinary tract infection (UTI), commonly caused by uropathogenic E.coli (UPEC), affects more than 150 million people worldwide, resulting in 14 million hospital visits per year and an estimated total cost of 6 billion dollars in direct health care. Due to the high prevalence of UTI and rapid emergence of antibiotic-resistant bacteria, new effective strategies to prevent and treat UTI are urgently needed. Here, we describe a global regulatory role of transcription factor hypoxia-inducible factor-1 (HIF-1) in innate antimicrobial defense against UPEC. HIF-1 stabilization reduces UPEC attachment to and invasion of uroepithelial cells, and protects bladders from UPEC-mediated cytotoxicity in vivo. In the murine UTI model, we found normal bladder HIF-1 expression is required for efficient UPEC clearance, since HIF-1-deficient mice suffer more severe infection than normal mice. Further studies showed that key elements of host protection provided by HIF-1 regulation are uroepithelial cell nitric oxide and antimicrobial peptide production. This study provides valuable insight into the importance of HIF-1 in supporting host immunity during UTI and its potential as a therapeutic target.


Vyšlo v časopise: Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Infection. PLoS Pathog 11(4): e32767. doi:10.1371/journal.ppat.1004818
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004818

Souhrn

Urinary tract infection (UTI), commonly caused by uropathogenic E.coli (UPEC), affects more than 150 million people worldwide, resulting in 14 million hospital visits per year and an estimated total cost of 6 billion dollars in direct health care. Due to the high prevalence of UTI and rapid emergence of antibiotic-resistant bacteria, new effective strategies to prevent and treat UTI are urgently needed. Here, we describe a global regulatory role of transcription factor hypoxia-inducible factor-1 (HIF-1) in innate antimicrobial defense against UPEC. HIF-1 stabilization reduces UPEC attachment to and invasion of uroepithelial cells, and protects bladders from UPEC-mediated cytotoxicity in vivo. In the murine UTI model, we found normal bladder HIF-1 expression is required for efficient UPEC clearance, since HIF-1-deficient mice suffer more severe infection than normal mice. Further studies showed that key elements of host protection provided by HIF-1 regulation are uroepithelial cell nitric oxide and antimicrobial peptide production. This study provides valuable insight into the importance of HIF-1 in supporting host immunity during UTI and its potential as a therapeutic target.


Zdroje

1. Schappert SM, Rechtsteiner EA (2011) Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13: 1–38.

2. Fihn SD (2003) Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 349: 259–266. 12867610

3. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD (2000) Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10: 509–515. 11118930

4. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, et al. (1990) Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58: 1281–1289. 2182540

5. Rasko DA, Phillips JA, Li X, Mobley HL (2001) Identification of DNA sequences from a second pathogenicity island of uropathogenic Escherichia coli CFT073: probes specific for uropathogenic populations. J Infect Dis 184: 1041–1049. 11574920

6. Jantausch BA, O'Donnell R, Wiedermann BL (2000) Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr Nephrol 15: 236–240. 11149117

7. Ko YC, Mukaida N, Ishiyama S, Tokue A, Kawai T, et al. (1993) Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 61: 1307–1314. 8454332

8. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ (2001) Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol 166: 1148–1155. 11145696

9. Candela JV, Park E, Gerspach JM, Davidoff R, Stout L, et al. (1998) Evaluation of urinary IL-1α and IL-1β in gravid females and patients with bacterial cystitis and microscopic hematuria. Urol Res 26: 175–180. 9694599

10. Demirel I, Vumma R, Mohlin C, Svensson L, Save S, et al. (2012) Nitric oxide activates IL-6 production and expression in human renal epithelial cells. Am J Nephrol 36: 524–530. doi: 10.1159/000345351 23183248

11. Agace WW, Patarroyo M, Svensson M, Carlemalm E, Svanborg C (1995) Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism. Infect Immun 63: 4054–4062. 7558319

12. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, et al. (2012) Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36: 616–648. doi: 10.1111/j.1574-6976.2012.00339.x 22404313

13. Smith YC, Rasmussen SB, Grande KK, Conran RM, O'Brien AD (2008) Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun 76: 2978–2990. doi: 10.1128/IAI.00075-08 18443089

14. Mysorekar IU, Isaacson-Schmid M, Walker JN, Mills JC, Hultgren SJ (2009) Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. Cell Host Microbe 5: 463–475. doi: 10.1016/j.chom.2009.04.005 19454350

15. Hellerstein S (2000) Long-term consequences of urinary tract infections. Curr Opin Pediatr 12: 125–128. 10763761

16. Rosenberg M (1999) Pharmacoeconomics of treating uncomplicated urinary tract infections. Int J Antimicrob Agents 11: 247–251; discussion 261–244. 10394978

17. Grover S, Srivastava A, Lee R, Tewari AK, Te AE (2011) Role of inflammation in bladder function and interstitial cystitis. Ther Adv Urol 3: 19–33. doi: 10.1177/1756287211398255 21789096

18. Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ (2010) Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6: e1001042. doi: 10.1371/journal.ppat.1001042 20811584

19. Huang LE, Arany Z, Livingston DM, Bunn HF (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253–32259. 8943284

20. Zinkernagel AS, Johnson RS, Nizet V (2007) Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) 85: 1339–1346. 18030436

21. Nizet V, Johnson RS (2009) Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9: 609–617. doi: 10.1038/nri2607 19704417

22. Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364: 656–665. doi: 10.1056/NEJMra0910283 21323543

23. Berger EA, McClellan SA, Vistisen KS, Hazlett LD (2013) HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog 9: e1003457. doi: 10.1371/journal.ppat.1003457 23874197

24. Peyssonnaux C, Boutin AT, Zinkernagel AS, Datta V, Nizet V, et al. (2008) Critical role of HIF-1α in keratinocyte defense against bacterial infection. J Invest Dermatol 128: 1964–1968. doi: 10.1038/jid.2008.27 18323789

25. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, et al. (2005) HIF-1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115: 1806–1815. 16007254

26. Muchnik E, Kaplan J (2011) HIF prolyl hydroxylase inhibitors for anemia. Expert Opin Investig Drugs 20: 645–656. doi: 10.1517/13543784.2011.566861 21406036

27. Denny WA (2012) Giving anemia a boost with inhibitors of prolyl hydroxylase. J Med Chem 55: 2943–2944. doi: 10.1021/jm300314a 22409479

28. Zinkernagel AS, Peyssonnaux C, Johnson RS, Nizet V (2008) Pharmacologic augmentation of hypoxia-inducible factor-1α with mimosine boosts the bactericidal capacity of phagocytes. J Infect Dis 197: 214–217. doi: 10.1086/524843 18173364

29. Okumura CY, Hollands A, Tran DN, Olson J, Dahesh S, et al. (2012) A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J Mol Med (Berl) 90: 1079–1089. doi: 10.1007/s00109-012-0882-3 22371073

30. Keely S, Campbell EL, Baird AW, Hansbro PM, Shalwitz RA, et al. (2014) Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal Immunol 7: 114–123. doi: 10.1038/mi.2013.29 23695513

31. Elks PM, Brizee S, van der Vaart M, Walmsley SR, van Eeden FJ, et al. (2013) Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism. PLoS Pathog 9: e1003789. doi: 10.1371/journal.ppat.1003789 24367256

32. Palit V, Phillips RM, Puri R, Shah T, Bibby MC (2005) Expression of HIF-1α and Glut-1 in human bladder cancer. Oncol Rep 14: 909–913. 16142350

33. Leire E, Olson J, Isaacs H, Nizet V, Hollands A (2013) Role of hypoxia inducible factor-1 in keratinocyte inflammatory response and neutrophil recruitment. J Inflamm (Lond) 10: 28. doi: 10.1186/1476-9255-10-28 23937964

34. Berry RE, Klumpp DJ, Schaeffer AJ (2009) Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun 77: 2762–2772. doi: 10.1128/IAI.00323-09 19451249

35. Wang Z, Humphrey C, Frilot N, Wang G, Nie Z, et al. (2011) Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli. J Cell Biol 192: 101–110. doi: 10.1083/jcb.201003027 21220511

36. Eto DS, Jones TA, Sundsbak JL, Mulvey MA (2007) Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3: e100. 17630833

37. Steele-Mortimer O, Brumell JH, Knodler LA, Meresse S, Lopez A, et al. (2002) The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells. Cell Microbiol 4: 43–54. 11856172

38. Elsinghorst EA, Baron LS, Kopecko DJ (1989) Penetration of human intestinal epithelial cells by Salmonella: molecular cloning and expression of Salmonella typhi invasion determinants in Escherichia coli. Proc Natl Acad Sci U S A 86: 5173–5177. 2662196

39. Lin AE, Autran CA, Espanola SD, Bode L, Nizet V (2014) Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. J Infect Dis 209: 389–398. doi: 10.1093/infdis/jit464 23990566

40. Mulvey MA, Schilling JD, Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69: 4572–4579. 11402001

41. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ (2007) Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4: e329. 18092884

42. Dhakal BK, Mulvey MA (2012) The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11: 58–69. doi: 10.1016/j.chom.2011.12.003 22264513

43. Bien J, Sokolova O, Bozko P (2012) Role of θropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012: 681473. doi: 10.1155/2012/681473 22506110

44. Tsai KW, Lai HT, Tsai TC, Wu YC, Yang YT, et al. (2009) Difference in the regulation of IL-8 expression induced by uropathogenic E. coli between two kinds of urinary tract epithelial cells. J Biomed Sci 16: 91. doi: 10.1186/1423-0127-16-91 19799797

45. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, et al. (2006) Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun 74: 5106–5113. 16926402

46. Song H, Ki SH, Kim SG, Moon A (2006) Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 66: 10487–10496. 17079470

47. Wang Q, Guo XL, Wells-Byrum D, Noel G, Pritts TA, et al. (2008) Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured Caco-2 cells. Shock 29: 531–537. 17724435

48. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, et al. (2011) Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta). J Neuroinflammation 8: 79. doi: 10.1186/1742-2094-8-79 21733175

49. Hung CS, Dodson KW, Hultgren SJ (2009) A murine model of urinary tract infection. Nat Protoc 4: 1230–1243. doi: 10.1038/nprot.2009.116 19644462

50. Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL (2012) Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun 80: 4186–4194. doi: 10.1128/IAI.00684-12 22988014

51. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, et al. (2005) Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 102: 431–436. 15625114

52. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, et al. (2008) Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 76: 3337–3345. doi: 10.1128/IAI.00090-08 18411285

53. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ (2000) Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 97: 8829–8835. 10922042

54. Lirk P, Hoffmann G, Rieder J (2002) Inducible nitric oxide synthase—time for reappraisal. Curr Drug Targets Inflamm Allergy 1: 89–108. 14561209

55. Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI (2002) Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J Biol Chem 277: 7412–7419. 11744708

56. Poljakovic M, Persson K (2003) Urinary tract infection in iNOS deficient mice with focus on bacterial sensitivity to nitric oxide. Am J Physiol 284: F22–31. 12494944

57. Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, et al. (2010) Vitamin D induction of the human antimicrobial πeptide cathelicidin in the urinary bladder. PLoS One 5: e15580. doi: 10.1371/journal.pone.0015580 21179490

58. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636–641. 16751768

59. Lehmann J, Retz M, Harder J, Krams M, Kellner U, et al. (2002) Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis 2: 20. 12238953

60. Ali AS, Townes CL, Hall J, Pickard RS (2009) Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 182: 21–28. doi: 10.1016/j.juro.2009.02.124 19447447

61. Anderson GG, Dodson KW, Hooton TM, Hultgren SJ (2004) Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 12: 424–430. 15337164

62. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, et al. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112: 645–657. 12628185

63. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, et al. (2007) Cutting edge: Essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J Immunol 178: 7516–7519. 17548584

64. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. (2008) NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453: 807–811. doi: 10.1038/nature06905 18432192

65. Giannakopoulos X, Evangelou A, Kalfakakou V, Grammeniatis E, Papandropoulos I, et al. (1997) Human bladder urine oxygen content: implications for urinary tract diseases. Int Urol Nephrol 29: 393–401. 9405994

66. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL (2010) Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6: e1001187. doi: 10.1371/journal.ppat.1001187 21085611

67. Koslowski M, Luxemburger U, Tureci O, Sahin U (2011) Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α. Oncogene 30: 876–882. doi: 10.1038/onc.2010.481 21042279

68. Glauser MP, Meylan P, Bille J (1987) The inflammatory response and tissue damage. The example of renal scars following acute renal infection. Pediatr Nephrol 1: 615–622. 3153342

69. Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69: 34–40. 17462477

70. Zasloff M (2007) Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18: 2810–2816. 17942949

71. Kim JH, Kim SJ, Lee KM, Chang IH (2013) Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells. BJU Int 112: 781–790. doi: 10.1111/bju.12196 23819923

72. Carlsson S, Govoni M, Wiklund NP, Weitzberg E, Lundberg JO (2003) In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria. Antimicrob Agents Chemother 47: 3713–3718. 14638471

73. Bang CS, Kinnunen A, Karlsson M, Onnberg A, Soderquist B, et al. (2014) The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide. BMC Microbiol 14: 65. doi: 10.1186/1471-2180-14-65 24629000

74. Xu J, Xu X, Verstraete W (2001) The bactericidal effect and chemical reactions of acidified nitrite under conditions simulating the stomach. J Appl Microbiol 90: 523–529. 11309062

75. Zhao J, Wang Z, Chen X, Wang J, Li J (2011) Effects of intravesical liposome-mediated human β-defensin-2 gene transfection in a mouse urinary tract infection model. Microbiol Immunol 55: 217–223. doi: 10.1111/j.1348-0421.2011.00315.x 21272062

76. Nielsen KL, Dynesen P, Larsen P, Jakobsen L, Andersen PS, et al. (2014) Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect Immun 82: 1572–1578. doi: 10.1128/IAI.01393-13 24452682

77. Bodenmiller DM, Spiro S (2006) The yjeB (nsrR) gene of Escherichia coli encodes a nitric oxide-sensitive transcriptional regulator. J Bacteriol 188: 874–881. 16428390

78. Sandau KB, Fandrey J, Brune B (2001) Accumulation of HIF-1α under the influence of nitric oxide. Blood 97: 1009–1015. 11159530

79. Zhou J, Fandrey J, Schumann J, Tiegs G, Brune B (2003) NO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells. Am J Physiol Cell Physiol 284: C439–446. 12388069

80. Dason S, Dason JT, Kapoor A (2011) Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J 5: 316–322. doi: 10.5489/cuaj.11214 22031610

81. Xue X, Ramakrishnan SK, Shah YM (2014) Activation of HIF-1α does not increase intestinal tumorigenesis. Am J Physiol Gastrointest Liver Physiol 307: G187–195. doi: 10.1152/ajpgi.00112.2014 24875099

82. Eltzschig HK, Bratton DL, Colgan SP (2014) Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov 13: 852–869. doi: 10.1038/nrd4422 25359381

83. Laubach VE, Shesely EG, Smithies O, Sherman PA (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92: 10688–10692. 7479866

84. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. 11328886

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2015 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#